Melodica Orchestra for Dyspnea: Safety and Feasibility Pilot

Overview

This project seeks to pilot-test the feasibility of using a melodica training program to teach pursed lip breathing for Veterans with chronic obstructive pulmonary disease (COPD) with moderate to severe dyspnea (shortness of breath). Dyspnea occurs commonly among COPD patients and can limit activities of daily living. Pursed lip breathing is a strategy that can improve dyspnea and exercise capacity among COPD patients. The melodica is a musical instrument that looks like a keyboard with a mouthpiece on the side. The melodica is played by exhaling through the mouthpiece while pressing the keys. The MELODY pilot project protocol has been grounded on concepts from occupational therapy; specifically, providing participants with a meaningful new activity that is enjoyable, that can be provided across a spectrum of skill levels, that can provide participants with a new sense of self, and that can improve health outcomes (i.e., dyspnea and exercise endurance).

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 31, 2019

Detailed Description

SPECIFIC AIMS: Primary Aim 1: Evaluate the safety of a melodica training program to teach pursed lip breathing among Veterans with COPD with moderate to severe dyspnea. We hypothesize that a melodica training program can be safely implemented among COPD patients with severe dyspnea. Primary Aim 2: Evaluate the feasibility of implementing a melodica training program to teach pursed lip breathing among Veterans with COPD with dyspnea. We hypothesize that it will be feasible to implement a melodica training program to teach pursed lip breathing among Veterans with COPD and dyspnea; specifically that enrolled participants will attend >50% of sessions. We also hypothesize that transportation to the VA Medical Center to attend sessions will be identified as a significant barrier to participation. Secondary Aim: Collect pilot-efficacy data of a melodica training program to teach pursed lip breathing among Veterans with COPD and dyspnea. The objective is to understand whether melodica training improves dyspnea both in the short-term and in the longer-term over the course of the 8-week training program. We hypothesize that a melodica training program will reduce dyspnea by 30% in the short-term and 10% in the long-term. We also hypothesize that intervention participants will show gains in the secondary efficacy outcome measures of exercise endurance, pulmonary function, entering pulmonary rehabilitation, quality of life, patient global impression of change, and anxiety relative to controls. RANDOMIZATION AND INTERVENTION: Randomization: Participants will be randomized in a 1:1:1 ratio to the intervention group (N=50), usual care control group (N=50), and education control group (N=50) using a block randomization design. We will also seek to identify N=30 Veterans who met the COPD diagnosis and spirometry eligibility criteria but who chose not to participate in the intervention; these Veterans will be invited to participate in a brief interview to identify barriers to participation. Melodica Program Intervention: The intervention program will include: education about pursed lip breathing, instruction in the melodica instrument, and participation in a melodica playing group which will meet twice-weekly for a 8-week period. Participants will be given instructional materials for use in practicing the instrument in their homes and encouragement to use pursed lip breathing not only while playing the instrument but also in their activities of daily living. Each session will last one hour in duration with approximately 20 minutes for instruction, 30 minutes in group music-making, and 10 minutes allocated for educational information about COPD, tobacco cessation, and pulmonary rehabilitation. Education Group: The patients in the education control group will receive the same educational materials that are provided to the intervention group; however, they will receive them in a single educational session. As described above, the educational materials include information about pursed lip breathing, COPD, medications used to treat COPD, how to use an inhaler, smoking cessation, pulmonary rehabilitation, oxygen therapy, exercise, and travelling with COPD. The materials include handouts as well as links to web pages.

Interventions

  • Behavioral: Melodica Intervention
    • The melodica program will include education about pursed lip breathing, instruction in the melodica instrument, and participation in a melodica training group which meets twice-weekly for an 8-week period. Each session will include musical instruction, group music-making, and education about COPD and related health topics.
  • Behavioral: Pulmonary Health Education
    • A single session including education about COPD and related health topics.

Arms, Groups and Cohorts

  • Experimental: Melodica Intervention
    • An 8-week group intervention including twice-weekly sessions. Each session will last one hour in duration with approximately 20 minutes for instruction, 30 minutes in group music-making, and 10 minutes allocated for educational information about COPD, tobacco cessation, and pulmonary rehabilitation.
  • Active Comparator: Education Control
    • A single 90-120 minute education session including the same educational information about COPD, tobacco cessation, and pulmonary rehabilitation provided to the melodica intervention group.
  • No Intervention: Usual Care Control
    • Usual care at Richard L. Roudebush VA Medical Center.
  • No Intervention: Interview Only
    • Semi-structured interviews will be conducted with Veterans who meet eligibility criteria, but who do not agree to participate in the intervention, to identify potential barriers to participation

Clinical Trial Outcome Measures

Primary Measures

  • Safety: Adverse Events
    • Time Frame: Measured at baseline and before and after each of 16 program training sessions (8 week duration).
    • We will describe the frequency with which patients reported any adverse events they experienced as a consequence of participation in the program as well as specify the types of adverse events.
  • Safety: Dyspnea Visual Analog Line
    • Time Frame: Baseline, before and after each training session (16 sessions over 8 weeks)
    • We will measure dyspnea with a visual-analog line (100mm line with anchors at 0=no dyspnea, 100=severe dyspnea)

Secondary Measures

  • Feasibility: Program Participation
    • Time Frame: Measured at baseline
    • Feasibility will be measured in terms of the proportion of eligible Veterans who agree to participate
  • Feasibility: Attendance
    • Time Frame: Measured at every intervention session (total of 16 sessions over 8 weeks)
    • Feasibility will be measured in terms of the proportion of sessions that enrolled participants attend

Participating in This Clinical Trial

Inclusion Criteria

  • spirometry-confirmed COPD defined as a FEV1/FVC <0.7 – moderate or severe dyspnea defined as a grade ≥3 on the ATS Dyspnea scale Exclusion Criteria:

  • visual or hearing impairments – do not speak English – do not have an intact airway – have cognitive impairment – are unable to make a seal with their mouths – have a history of at least one hospital admission for congestive heart failure in the prior year – receiving Hospital-Based Home Care (HBHC) or Telehealth care for COPD management

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • VA Quality Enhancement Research Intiative
  • Provider of Information About this Clinical Study
    • Principal Investigator: Dawn M. Bravata, Professor of Medicine & Adjunct Professor of Neurology – VA Quality Enhancement Research Intiative
  • Overall Official(s)
    • Dawn M Bravata, MD, Principal Investigator, VA Quality Enhancement Research Initiative

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.